Showing results 1 to 20 of 57
next >
| Issue Date | Title | Author(s) |
| 2018-01 | A retrospective audit on usage of Diatrizoate Meglumine (Gastrografin®) for intestinal obstruction or constipation in patients with advanced neoplasms. | Heng, S; Hardy, J; Good, P |
| 2011-05-01 | Aggregating single patient (n-of-1) trials in populations where recruitment and retention was difficult: The case of palliative care | Nikles, J; Mitchell, GK; Schluter, P; Good, P; Hardy, J; Rowett, D; Shelby-James, T; Vohra, S; Currow, D |
| 2017-02 | An open-label pilot study of oral vitamin C as an opioid-sparing agent in patients with chronic pain secondary to cancer. | Pinkerton, E; Good, P; Gibbons, K; Hardy, J |
| 2013-02-01 | The art of letting go: Referral to palliative care and its discontents | Broom, A; Kirby, E; Good, P; Wootton, J; Adams, J |
| 2017-10 | Assessing the practice of palliative care doctors: what driving advice do they give patients with advanced disease? | Weir, N; Fischer, A; Good, P |
| 2022-10-19 | Association of KCNJ6 rs2070995 and methadone response for pain management in advanced cancer at end-of-life. | Ozberk, D; Haywood, A; Sutherland, HG; Yu, C; Albury, CL; Zunk, M; George, R; Good, P; Griffiths, LR; Hardy, J; Haupt, LM |
| 2022-04 | Association of polymorphisms in ARRB2 and clinical response to methadone for pain in advanced cancer. | Ozberk, D; Haywood, A; Sutherland, HG; Yu, C; Albury, CL; Zunk, M; George, R; Good, P; Griffiths, LR; Hardy, J; Haupt, LM |
| 2017-09 | Can Saliva and Plasma Methadone Concentrations Be Used for Enantioselective Pharmacokinetic and Pharmacodynamic Studies in Patients With Advanced Cancer? | George, R; Haywood, A; Good, P; Hennig, S; Khan, S; Norris, R; Hardy, J |
| 2018-03-04 | Characteristics of community palliative care patients requiring acute admission to hospital | Jessop, M; Fischer, A; McNeilly, A; May, A; Good, P |
| 2017-07-03 | Corticosteroids for adult patients with advanced cancer who have nausea and vomiting (not related to chemotherapy, radiotherapy, or surgery). | Vayne-Bossert, P; Haywood, A; Good, P; Khan, S; Rickett, K; Hardy, JR |
| 2023-07-03 | Defining research priorities and needs in cancer symptoms for adults diagnosed with cancer: an Australian/New Zealand modified Delphi study. | Yenson, VM; Amgarth-Duff, I; Brown, L; Caperchione, CM; Clark, K; Cross, A; Good, P; Landers, A; Luckett, T; Philip, J; Steer, C; Vardy, JL; Wong, AK; Agar, MR |
| 2013-11-18 | Do pilocarpine drops help dry mouth in palliative care patients: A protocol for an aggregated series of n-of-1 trials | Nikles, J; Mitchell, GK; Hardy, J; Agar, M; Senior, H; Carmont, SA; Schluter, PJ; Good, P; Vora, R; Currow, D |
| 2022-04 | Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer? | Lord, S; Hardy, J; Good, P |
| 2015-09-01 | The effect of methylphenidate on fatigue in advanced cancer: An aggregated N-of-1 trial | Mitchell, GK; Hardy, JR; Nikles, CJ; Carmont, SAS; Senior, HE; Schluter, PJ; Good, P; Currow, DC |
| 2021-01-01 | Emotionally reflexive labour in end-of-life communication. | Olson, RE; Smith, A; Good, P; Neate, E; Hughes, C; Hardy, J |
| 2022-01-01 | Evaluation of a nurse practitioner role within a specialist palliative care service in Australia | Fischer, A; May, A; Lancaster, M; Alexander, K; Good, P |
| 2017-10 | Experiences of interpreters in supporting the transition from oncology to palliative care: A qualitative study. | Kirby, E; Broom, A; Good, P; Bowden, V; Lwin, Z |
| 2014-01-01 | Families and the transition to specialist palliative care | Kirby, E; Broom, A; Good, P; Wootton, J; Adams, J |
| 2019-09-01 | Harms From Haloperidol for Symptom Management in Palliative Care—a Post Hoc Pooled Analysis of Three Randomized Controlled Studies and Two Consecutive Cohort Studies | Matsuoka, H; Agar, M; Vandersman, Z; Good, P; Fazekas, B; Brown, L; Hardy, J; Weil, J; Currow, DC |
| 2021-10-09 | Hopeful dying? The meanings and practice of hope in palliative care family meetings. | Kirby, E; Broom, A; MacArtney, J; Lewis, S; Good, P |
